Cetamide and Oedema peripheral - a phase IV clinical study of FDA data

Summary:

Oedema peripheral is reported as a side effect among people who take Cetamide (sulfacetamide sodium), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Lasix, and have Osteoporosis.

The phase IV clinical study analyzes which people have Oedema peripheral when taking Cetamide. It is created by eHealthMe based on reports of 1,032 people who have side effects when taking Cetamide from the FDA, and is updated regularly.

What is Cetamide?

Cetamide has active ingredients of sulfacetamide sodium. eHealthMe is studying from 1,053 Cetamide users. Check the latest studies of Cetamide.

What is Oedema peripheral?

Oedema peripheral (superficial swelling) is found to be associated with 2,772 drugs and 3,465 conditions by eHealthMe. Check the latest studies of Oedema peripheral.



On Jul, 12, 2026

1,032 people reported to have side effects when taking Cetamide.
Among them, 21 people (2.03%) have Oedema peripheral.

Could Cetamide cause Oedema peripheral?

Among these 21 people:

How long have people been on Cetamide when they have Oedema peripheral? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Oedema peripheral when taking Cetamide? *

  • female: 94.74 %
  • male: 5.26 %

What is the age of people who have Oedema peripheral when taking Cetamide? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 12.5 %
  • 30-39: 18.75 %
  • 40-49: 6.25 %
  • 50-59: 6.25 %
  • 60+: 56.25 %

What are other drugs people take besides Cetamide? *

  1. Lasix: 8 people, 38.10%
  2. Aspirin: 7 people, 33.33%
  3. Singulair: 7 people, 33.33%
  4. Nexium: 7 people, 33.33%
  5. Atrovent: 7 people, 33.33%
  6. Lisinopril: 7 people, 33.33%
  7. Nitroglycerin: 6 people, 28.57%
  8. Cardizem Sr: 6 people, 28.57%
  9. Asmanex Twisthaler: 6 people, 28.57%
  10. Altace: 6 people, 28.57%

What are other side effects people have besides Oedema peripheral? *

  1. Pain: 9 people, 42.86%
  2. Back Pain: 8 people, 38.10%
  3. Urinary Tract Infection: 8 people, 38.10%
  4. Feeling Abnormal: 7 people, 33.33%
  5. Spinal Column Stenosis (narrowing of spinal column): 7 people, 33.33%
  6. Muscle Spasms (muscle contraction): 7 people, 33.33%
  7. Wound: 6 people, 28.57%
  8. Procedural Complication: 6 people, 28.57%
  9. Nausea And Vomiting: 6 people, 28.57%
  10. Bone Pain: 6 people, 28.57%

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 9 people, 42.86%
  2. Urination - Excessive Volume: 3 people, 14.29%
  3. Sedation: 3 people, 14.29%
  4. Multiple Allergies (allergy to multiple agents): 2 people, 9.52%
  5. Acne (skin problems that cause pimples): 2 people, 9.52%
  6. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 9.52%
  7. Quit Smoking: 1 person, 4.76%
  8. Pain: 1 person, 4.76%
  9. Sinus Disorder (disease of sinus): 1 person, 4.76%
  10. Nausea (feeling of having an urge to vomit): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Cetamide and have Oedema peripheral?

- Check whether Oedema peripheral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cetamide:

Oedema peripheral treatments and more:

How severe was Oedema peripheral and when was it recovered:

Expand to all the drugs that have ingredients of sulfacetamide sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cetamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oedema peripheral:

Browse all the conditions that are associated with Oedema peripheral:


How the study uses the data?

The study uses data from the FDA. It is based on sulfacetamide sodium (the active ingredients of Cetamide) and Cetamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: